PMI’s FDA-approved SynCardia STAH is promising, but adoption and revenues lag; cash burn and dilution weigh. Read the full ...

Avoid false market narratives in 2026: why Exxon, Chevron & COP face oil oversupply risk, while AI-driven tech stays bullish.

Jan. 16, 2026 A vitamin A byproduct has been found to quietly disarm the immune system, allowing tumors to evade attack and weakening cancer vaccines. Scientists have now developed a drug that shuts ...